The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

Thank you for being a part of the Cancer Survivor Network community. Survivors and caregivers like you have played a unique role in fostering an online environment that encourages connection among those needing support, community, and education. On May 28, the Network will be discontinued. More details are available here . If you have any questions, contact CSNSupportTeam@cancer.org. Thanks again for the support you’ve provided each other over the years. We remain committed to supporting you in other ways throughout your cancer journey.

Adrenalcortical Carcinoma Clinical Trial

steve59
steve59 CSN Member Posts: 1

Good morning,  I am battling adrenalcortical carcinoma.  After surgery,  mitotane therapy and chemo my cancer became active again. I want to let everyone battling this type of cancer know that currently there is a new clinical trial being conducting at The National Institute for Health. They are actively seeking ACC patients to participate.

I am currently particpating. I happened to stumble across this trial in January, right after it opened. You can get more info at 

Www.clinicaltrials.gov

Search on "adrenalcortical carcinoma"

The study title is Centredekin Besudotox (IL-13-PE)

I am happy to answer any questions that you may have about this trial.

Steve 

 

Comments

  • Emmasykes
    Emmasykes CSN Member Posts: 2
    Adrenal Cancer

    Hi Steve, your post interested me, I'm in England, I've had cushings disease, 10 cm cancerous tumour removed in May, ct scan last month shows clear, but they can't be sure no cancel cells escaped from tumour so have started me on mitotane, I'm 6 days in, I'm very scared as they say if it comes back very very serious, with mitotane gives me 30 per cent chance of killing cells?  What is the name of drug your on? Did they offer you mitotane ?   Thanks Emma